CVS Health Q1 Adj EPS $2.25 vs $1.31 YoY; raises FY25 Adj EPS guidance to $6.00-$6.20

CVS HEALTH Corp

2025-Q1 EPS reported $1.41 revenue$94,588,000,000

Total revenues $94.6B, up 7.0% YoY; GAAP diluted EPS $1.41, Adjusted EPS $2.25.
Operating income $3.374B vs $2.271B YoY; adjusted operating income $4.579B vs $2.957B.
Full-year 2025 guidance: GAAP diluted EPS revised to $4.23-$4.43 from $4.58-$4.83; Adjusted EPS raised to $6.00-$6.20 from $5.75-$6.00.
CVS Health to exit individual exchange business; introduces Aetna solutions and CVS Caremark GLP-1 formulary update.
Cash flow from ops $4.6B in Q1; FY25 CF guidance raised to ~$7.0B from ~$6.5B.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.